VERA THERAPEUTICS INC (VERA)
US92337R1014 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -95.99M | -89.06M | -32.61M | -53.41M | -11.85M | |||
| Depreciation Amortization | N/A | N/A | 180.00K | 250.00K | 510.00K | |||
| Change In Working Capital | -5.87M | 6.75M | 3.51M | 120.00K | 520.00K | |||
| Interest Paid | 3.35M | 900.00K | 20.00K | 30.00K | 50.00K | |||
| Other non cash items | 9.68M | 14.71M | 5.21M | 18.23M | 540.00K | |||
| OPERATING CASH FLOW | -92.18M | -67.60M | -23.71M | -34.81M | -10.29M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -63.00K | -60.00K | -5.00M | -100.00K | -130.00K | |||
| Other Investing Activity | -39.37M | -70.49M | 800.00K | 60.00K | 0.00 | |||
| INVESTING CASH FLOW | -39.43M | -70.55M | -4.20M | -40.00K | -130.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 24.74M | 19.82M | 4.92M | -130.00K | -190.00K | |||
| Stock Issued/Repurchased | 116.06M | 88.21M | 51.73M | 85.83M | 50.00K | |||
| Other Financing Activity | -7.26M | -6.10M | -2.77M | -410.00K | 0.00 | |||
| FINANCING CASH FLOW | 133.54M | 101.93M | 53.88M | 85.29M | -140.00K | |||
| CHANGE IN CASH | 1.93M | -36.22M | 25.97M | 50.44M | -10.56M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -92.18M | -67.60M | -23.71M | -34.81M | -10.29M | |||
| Capital Expenditure | -63.00K | -60.00K | -5.00M | -100.00K | -130.00K | |||
| FREE CASH FLOW | -92.24M | -67.66M | -28.71M | -34.91M | -10.42M | |||
All data in USD